Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Mares

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Journal of the American Heart Association|December 30, 2025
Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Women With Severe Aortic Stenosis: The RHEIA TrialIria Silva, Alberto Alperi, Sébastien Hecht, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|April 28, 2023
The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021Dominika Stastna, Jiri Drahota, Michal Lauer, et al.
Multiple Sclerosis and Related Disorders|June 17, 2023
Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registriesTereza Hrnciarova, Jiri Drahota, Tim Spelman, et al.
Journal of Central Nervous System Disease|July 26, 2024
Real-world effectiveness of cladribine as an escalation strategy for MS: Insights from the Czech nationwide ReMuS registryPavel Potuznik, Jiri Drahota, Dana Horakova, et al.
Multiple Sclerosis and Related Disorders|June 22, 2023
Is breastfeeding in MS harmful or not? An answer from real-world Czech dataPavel Hradilek, Olga Zapletalova, Petra Hanulikova, et al.
European Heart Journal. Acute Cardiovascular Care|March 4, 2025
Clinical characteristics, management and predictors of mortality: results from national prospective cardiogenic shock registry (CZECH-SHOCK)Michal Pazdernik, Petr Ostadal, Jiri Seiner, et al.
Endoscopy|November 25, 2025
Correction: Gastric peroral endoscopic pyloromyotomy for refractory gastroparesis following esophagectomy: results from a multicenter seriesPierre-Jean Silete, Magdalena Houzvickova, Thibault Degand, et al.
Endoscopy|November 4, 2025
Gastric peroral endoscopic pyloromyotomy for refractory gastroparesis following esophagectomy: results from a multicenter seriesPierre-Jean Silete, Magdalena Houzvickova, Thibault Degand, et al.
The Lancet. Gastroenterology & Hepatology|March 20, 2025
Per-oral endoscopic myotomy versus laparoscopic Heller's myotomy plus Dor fundoplication in patients with idiopathic achalasia: 5-year follow-up of a multicentre, randomised, open-label, non-inferiority trialKristina Hugova, Jan Mares, Bengt Hakanson, et al.
CNS Neuroscience & Therapeutics|April 24, 2013
Recommendations for the use of prolonged-release fampridine in patients with multiple sclerosis (MS)Jana Lizrova Preiningerova, Ulf Baumhackl, Tunde Csepany, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Journal of the American Heart Association|December 30, 2025
Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Women With Severe Aortic Stenosis: The RHEIA TrialIria Silva, Alberto Alperi, Sébastien Hecht, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|April 28, 2023
The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021Dominika Stastna, Jiri Drahota, Michal Lauer, et al.
Multiple Sclerosis and Related Disorders|June 17, 2023
Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registriesTereza Hrnciarova, Jiri Drahota, Tim Spelman, et al.
Journal of Central Nervous System Disease|July 26, 2024
Real-world effectiveness of cladribine as an escalation strategy for MS: Insights from the Czech nationwide ReMuS registryPavel Potuznik, Jiri Drahota, Dana Horakova, et al.
Multiple Sclerosis and Related Disorders|June 22, 2023
Is breastfeeding in MS harmful or not? An answer from real-world Czech dataPavel Hradilek, Olga Zapletalova, Petra Hanulikova, et al.
European Heart Journal. Acute Cardiovascular Care|March 4, 2025
Clinical characteristics, management and predictors of mortality: results from national prospective cardiogenic shock registry (CZECH-SHOCK)Michal Pazdernik, Petr Ostadal, Jiri Seiner, et al.
Endoscopy|November 25, 2025
Correction: Gastric peroral endoscopic pyloromyotomy for refractory gastroparesis following esophagectomy: results from a multicenter seriesPierre-Jean Silete, Magdalena Houzvickova, Thibault Degand, et al.
Endoscopy|November 4, 2025
Gastric peroral endoscopic pyloromyotomy for refractory gastroparesis following esophagectomy: results from a multicenter seriesPierre-Jean Silete, Magdalena Houzvickova, Thibault Degand, et al.
The Lancet. Gastroenterology & Hepatology|March 20, 2025
Per-oral endoscopic myotomy versus laparoscopic Heller's myotomy plus Dor fundoplication in patients with idiopathic achalasia: 5-year follow-up of a multicentre, randomised, open-label, non-inferiority trialKristina Hugova, Jan Mares, Bengt Hakanson, et al.
CNS Neuroscience & Therapeutics|April 24, 2013
Recommendations for the use of prolonged-release fampridine in patients with multiple sclerosis (MS)Jana Lizrova Preiningerova, Ulf Baumhackl, Tunde Csepany, et al.
Pageof 12